ATE79548T1 - Herpes simplex virus subunitimpfstoff. - Google Patents

Herpes simplex virus subunitimpfstoff.

Info

Publication number
ATE79548T1
ATE79548T1 AT84110308T AT84110308T ATE79548T1 AT E79548 T1 ATE79548 T1 AT E79548T1 AT 84110308 T AT84110308 T AT 84110308T AT 84110308 T AT84110308 T AT 84110308T AT E79548 T1 ATE79548 T1 AT E79548T1
Authority
AT
Austria
Prior art keywords
herpes simplex
simplex virus
vaccine
type
subunite
Prior art date
Application number
AT84110308T
Other languages
English (en)
Inventor
Yoichiro Kino
Nobuya Ohtomo
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE79548T1 publication Critical patent/ATE79548T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
AT84110308T 1983-08-31 1984-08-29 Herpes simplex virus subunitimpfstoff. ATE79548T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58159641A JPS6051120A (ja) 1983-08-31 1983-08-31 単純ヘルペスサブユニットワクチン
EP84110308A EP0135841B1 (de) 1983-08-31 1984-08-29 Herpes Simplex Virus Subunitimpfstoff

Publications (1)

Publication Number Publication Date
ATE79548T1 true ATE79548T1 (de) 1992-09-15

Family

ID=15698148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84110308T ATE79548T1 (de) 1983-08-31 1984-08-29 Herpes simplex virus subunitimpfstoff.

Country Status (9)

Country Link
US (1) US4661349A (de)
EP (1) EP0135841B1 (de)
JP (1) JPS6051120A (de)
KR (1) KR910005889B1 (de)
AT (1) ATE79548T1 (de)
AU (1) AU571569B2 (de)
CA (1) CA1244766A (de)
DE (1) DE3485873T2 (de)
SU (1) SU1554755A3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
WO1988002634A1 (en) * 1986-10-20 1988-04-21 Chiron Corporation Vaccine for use in the therapeutic treatment of hsv
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
EP0471778A1 (de) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Proteine und polypeptide des glykoproteins g vom herpes simplex-virus
US6174916B1 (en) 1990-04-27 2001-01-16 Milkhaus Laboratory, Ltd. Methods for treating herpes virus infections
JP3005292B2 (ja) * 1990-08-02 2000-01-31 カイロン コーポレイション 単純ヘルペスウィルスのｖｐ１６のワクチン
US5334503A (en) * 1991-10-08 1994-08-02 Eastman Kodak Company Test kit and method for the detection of microorganisms associated with periodontal diseases using surfactant mixture as extraction composition
US5807557A (en) * 1994-07-25 1998-09-15 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex
US6156319A (en) * 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
US6051385A (en) * 1997-10-22 2000-04-18 The Regents Of The University Of Michigan Compositions and methods for identifying and testing therapeutics against HSV infection
AU2001286407A1 (en) * 2000-08-01 2002-03-04 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds derived from the hsv gd protein and methods
EP1494030B1 (de) * 2003-06-30 2013-11-27 Sysmex Corporation Lösung zur Vorbehandlung eines Grippevirentests basierend auf Immunchromatographie
US20220193222A1 (en) * 2018-11-30 2022-06-23 Vaccine Stabilization Institute Viral formulations containing amino acids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
IT1117218B (it) * 1979-05-18 1986-02-17 Depa Sas Procedimento per la produzione di un prodotto per la diagnosi dei tumori delle parti molli o carcinomi e prodotto ottenuto
US4341754A (en) * 1980-01-24 1982-07-27 Vanderbilt University Diagnostic reagent for herpes simplex virus encephalitis
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4430437A (en) * 1980-08-27 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
US4535057A (en) * 1982-07-26 1985-08-13 Amf Incorporated Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
DK305784A (da) * 1983-06-23 1984-12-24 Stanley Person Ikke-glycosyleret aminosyrekaede af glycoprotein b fra herpes virus type 1 og 2
US4533496A (en) * 1984-05-08 1985-08-06 Monsanto Company Method of isolating monoclonal antibodies from hybridoma cultures

Also Published As

Publication number Publication date
AU3254184A (en) 1985-03-07
EP0135841B1 (de) 1992-08-19
KR850001700A (ko) 1985-04-01
DE3485873D1 (en) 1992-09-24
EP0135841A3 (en) 1986-05-28
KR910005889B1 (ko) 1991-08-06
AU571569B2 (en) 1988-04-21
US4661349A (en) 1987-04-28
SU1554755A3 (ru) 1990-03-30
EP0135841A2 (de) 1985-04-03
CA1244766A (en) 1988-11-15
JPS6051120A (ja) 1985-03-22
DE3485873T2 (de) 1993-03-25

Similar Documents

Publication Publication Date Title
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
IT8247706A0 (it) Procedimento per la produzione di virus vaccini
ATE162402T1 (de) Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff
EP0154344A3 (en) Antiviral pharmaceutical preparations and methods for their use
ATE118353T1 (de) Rekombinanter herpes simplex gb-gd impfstoff.
NO852567L (no) Thymopentinanaloger og fremgangsmmaate for deres fremstilling.
EP0203676A3 (en) Vaccine for generating an immunogenic t cell response protective against a virus
ES519875A0 (es) Procedimiento para aislar un preparado inmunologicamente activo de glicoproteina gd-1 con envoltura de virus de herpes simplex de tipo 1.
ES2035818T3 (es) Mutantes de delecion de la timidin-kinasa del virus del herpes bovino-1, vacunas contra la rinotraqueitis bovina infecciosa que los contienen y metodos para su produccion y uso.
SE8505121D0 (sv) Immunoregulator
PT833903E (pt) Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino
FI890116A0 (fi) Icke-reverterande rna-virus.
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
EP0115442A3 (de) Impfstoff und seine Verwendung gegen Pseudorabies Virus
ES8800358A1 (es) Un procedimiento para preparar un polipeptido hibrido.
ES2179839T3 (es) Macrocapsulas microporosas.
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES515472A0 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
IE830861L (en) Equine influenza vaccine.
ES2055610T3 (es) Vacuna contra hrsv.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
EP0244760A3 (de) Impfstoff zur Verhütung von Marek-Krankheit
GR3032621T3 (en) Extracts of piliostigma thonningii, the use thereof and formulations containing them.
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee